Neurocrine Biosciences Inc vs Carparts.Com Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Carparts.Com Inc trades at $5.09 (market cap $41.22M). The key difference: Neurocrine Biosciences Inc is far larger — about 422.1× Carparts.Com Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Carparts.Com Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | PRTS | |
|---|---|---|
Market Cap | $17.40B | $41.22M |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $11.40 |
52-Week Low | $123.10 | $3.88 |
Enterprise Value | $16.49B | $56.19M |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →